Lmcg Investments LLC Sells 603 Shares of Agilent Technologies, Inc. (NYSE:A)

Lmcg Investments LLC lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 0.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 79,628 shares of the medical research company’s stock after selling 603 shares during the quarter. Lmcg Investments LLC’s holdings in Agilent Technologies were worth $10,697,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Massachusetts Financial Services Co. MA increased its stake in shares of Agilent Technologies by 3.5% in the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock valued at $2,314,784,000 after buying an additional 525,214 shares during the period. FMR LLC increased its position in shares of Agilent Technologies by 62.2% during the third quarter. FMR LLC now owns 1,287,665 shares of the medical research company’s stock worth $191,193,000 after buying an additional 493,947 shares during the period. Worldquant Millennium Advisors LLC bought a new position in Agilent Technologies during the third quarter worth $49,449,000. Marshall Wace LLP lifted its holdings in Agilent Technologies by 48.6% in the second quarter. Marshall Wace LLP now owns 957,128 shares of the medical research company’s stock valued at $124,073,000 after buying an additional 313,155 shares during the period. Finally, Jennison Associates LLC boosted its position in Agilent Technologies by 63.3% during the third quarter. Jennison Associates LLC now owns 586,439 shares of the medical research company’s stock valued at $87,075,000 after acquiring an additional 227,431 shares during the last quarter.

Analysts Set New Price Targets

A has been the subject of several research analyst reports. Sanford C. Bernstein lowered their price objective on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. Bank of America lowered their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Evercore ISI increased their price target on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Barclays reduced their price objective on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating for the company in a research report on Wednesday, November 27th. Finally, Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research report on Monday, December 9th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $143.62.

Agilent Technologies Trading Up 2.0 %

Shares of A stock opened at $147.57 on Tuesday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09. The company has a market capitalization of $42.15 billion, a price-to-earnings ratio of 33.39, a PEG ratio of 3.71 and a beta of 1.06. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The company has a 50-day simple moving average of $136.48 and a two-hundred day simple moving average of $137.34.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.05. The company had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. During the same period in the prior year, the company posted $1.38 earnings per share. Agilent Technologies’s quarterly revenue was up .8% on a year-over-year basis. Research analysts anticipate that Agilent Technologies, Inc. will post 5.56 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be issued a $0.248 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, December 31st. Agilent Technologies’s payout ratio is 22.40%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.